Skip to main content
. 2020 Jul 10;13:2465–2476. doi: 10.2147/DMSO.S250463

Table 1.

Basic Characteristics of Normal Glucose Tolerance and Prediabetes Groups

Variables Total (n=422) Glucose Tolerance
Normal Glucose Tolerance (n=275) Prediabetes (n=147) P value*
Age (years) 27.77 ± 7.51 26.74 ± 7.05 29.68±7.98 <0.001
Male gender, n (%) 261 (61.85) 177 (64.36) 84 (57.14) 0.146
BMI (kg/m2) 34.84 ± 5.69 34.64 ± 5.50 35.22 ± 6.03 0.318
Neck circumference (cm) 41.96 ± 4.13 41.80±4.02 42.28 ± 4.34 0.319
Smoking status, n (%) 43 (10.19) 29 (10.55) 14 (9.52) 0.741
OSA, n (%) 257 (60.90) 151 (54.91) 106 (72.11) 0.001
Severe OSA, n (%) 109 (25.83) 62 (22.55) 47 (31.97) 0.035
AHI (events/h) 7.70 (2.20–31.98) 6.00 (1.70–27.20) 11.20 (3.90–49.90) 0.001
ODI (events/h) 14.25 (4.73–41.63) 11.55 (3.88–30.15) 23.45 (6.43–62.48) 0.001
Mean SpO2 (%) 94.56 ± 3.89 94.95 ± 3.29 93.87 ± 4.71 0.041
LSpO2 (%) 78.72 ± 15.90 80.46 ± 15.02 75.38 ± 17.02 0.003
TS90 (%) 0.50 (0.00–6.35) 0.30 (0.00–3.23) 1.90 (0.10–17.00) <0.001
HbA1c (%) 5.61 ± 0.59 5.48 ± 0.51 5.87 ± 0.65 <0.001
Fasting glucose (mmol/L) 5.17 ± 0.59 4.99 ± 0.43 5.50 ± 0.70 <0.001
2-h glucose (mmol/L) 7.23 ± 1.82 6.15 ± 1.03 9.23 ± 1.17 <0.001
Fasting insulin (mU/mL) 18.83 (12.45–26.30) 18.01(12.09–25.28) 20.39 (13.63–27.87) 0.048
2-h insulin (mU/mL) 118.50 (68.81–185.15) 105.00 (61.59–157.90) 154.10 (95.21–269.10) <0.001
HOMA-IR (μIU·mol·L−2) 4.20 (2.71–6.10) 3.99 (2.62–5.82) 5.05 (3.09–6.93) 0.001
HOMA-β (IU/mol) 231.12 (157.71–340.98) 245.25 (168.33–356.43) 203.90 (136.74–327.85) 0.008
ΔI30/ΔG30 (IU/mol) 28.54 (17.06–46.53) 34.07 (21.07–53.07) 20.39 (10.42–31.08) <0.001
AUC-I180 (μIU/mL·h) 343.69 (241.47–510.93) 331.33 (236.64–480.28) 359.17 (246.20–560.19) 0.062
DIO (L2/mmol2) 578.14 (434.76–717.85) 655.91 (542.36–806.56) 403.28 (316.25–537.81) <0.001

Notes: Quantitative data are presented as mean ± SD or median with inter-quartile range if variables were not normally distributed. *Normal glucose tolerance vs Prediabetes.

Abbreviations: OSA, obstructive sleep apnea; BMI, body mass index; AHI, apnea-hypopnea index; ODI, oxygen desaturation index; Mean SpO2, mean pulse oxygen saturation; LSpO2, lowest pulse oxygen saturation; TS90, percent of total sleep time spent below 90% oxygen saturation; HbA1c, glycosylated hemoglobin A1; HOMA-IR, homeostasis model assessment-insulin resistance; HOMA-β, homeostasis model assessment-β; ΔI30/ΔG30, the early phase (0 min−30 min) insulinogenic index; AUC-I180, total area under the curve of insulin in 180 minutes; DIO, oral disposition index.